Clinical Case Database / Category: Patient Management

Diagnosis and management of Parkinson's Disease dementia

Publication details

Authors Dr Alifa Isaacs-Itua BM BS, LLDip, BA (Hons), Dr Paritosh Sharma MB BS, MRCPsych, Dr Jim Bolton MB BS, BSc(Hons), FRCPsych,
Foundation Years Journal, volume 4, issue 3, p.15 (123Doc Education, London, March 2010)

Abstract

Idiopathic Parkinson's Disease (PD) is the most common neurodegenerative disorder. It usually presents between the fifth and seventh decades and has a prevalence of 150 per 100,000. Cognitive decline directly attributed to PD, known as Parkinson's Disease dementia (PDD), can affect up to 40% of those with PD. Risk factors for PDD include older age of onset of motor symptoms and co-morbid depression. Consequently, Foundation doctors should be alert to the symptoms of both cognitive impairment and depression in patients with PD. Management of PDD includes identifying and reducing exacerbating factors and effective communication with patients and carers.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Authors Dr Alifa Isaacs-Itua BM BS, LLDip, BA (Hons)

Foundation Doctor

Dr Paritosh Sharma MB BS, MRCPsych

Core Trainee in Psychiatry

Dr Jim Bolton MB BS, BSc(Hons), FRCPsych,

Consultant Liaison Psychiatrist and Honorary Senior Lecturer
Department of Liaison Psychiatry St Helier Hospital
Wrythe Lane
Carshalton, Surrey SM5 1AA
jim.bolton@swlstg-tr.nhs.uk

References

1. Reig SG, Marsh L (2003) Ten most commonly asked questions about the psychiatric aspects of Parkinson's disease. Neurologist, 9(1):50–56.
2. McDonald WM, Richard IH, Delong MR (2003) Prevalence, etiology, and treatment of depression in Parkinson's Disease. Biol Psychiatry, 54(3):363–375.
3. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinicial. Journal of psychiatric res, 12(3):189–198.
4. Emre M (2003) Dementia associated with Parkinson's Disease. Lancet Neurol, 2(4):229-237.
5. Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, Tolosa E, Dubois B. (2008) Diagnosis and management of Parkinson's disease dementia. Int J Clin Pract, 62(10):1581–1587.
6. Maidment I, Fox C, Boustani M (2006) Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev, 25(1):CD004747.
7. Richard IH, Justus AW, Greig NH, Marshall F, Kurlan R. (2002) Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine. Clin Neuropharmacol, 25(6):296–299.
8. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. (2006) Efficacy of rivastigmine in Dementia with Lewy Bodies: a randomised double-blind placebo-controlled international study. Lancet, 356(9247):2031–2036.
9. Factor SA, Weiner WJ. (eds) (2002) Parkinson's Disease: Diagnosis and Clinical Management. Demos Publishing. Available online from: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=parkinsons
10. Royal College of Physicians (2006) Parkinson's Disease. National clinical guideline for diagnosis and management in primary and secondary care. Available online from: http://www.nice.org.uk/nicemedia/pdf/cg035fullguideline.pdf
11. Brown J, Hillam J (2004) Your questions answered: Dementia, 1st edn. Edinburgh: Churchill Livingstone; 189–194.
12. Harder K, Tan M, Cote L, Stern Y, Mayeux R. (1995) The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol, 52:695–701.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.